Congratulations to Dr. Yale Michaels on receiving a $550,000 Canadian Cancer Society Grant to advance the next generation of CAR T-cell therapy for cancer. His research aims to develop stem cell-based CAR T treatments that could reduce costs, shorten wait times, and make it accessible for patients.

Congratulations to Dr. @cedricstremblay.bsky.social on receiving a Canadian Cancer Society Emerging Scholar Research grant valued at $550,000 over 5 years. His research will investigate why leukemia returns after treatment by studying the cancer cells that survive chemotherapy.

Dr. Ryan Zarychanski and Dr. Brett Houston helped lead a landmark Canadian study published in the New England Journal of Medicine. The study found that a low-cost medication can reduce the need for blood transfusions during major surgery without increasing the risk of dangerous clots.

Congratulations to Dr. Athanasios Zovoilis and his team on receiving a Manitoba Solutions Grant from Research Manitoba. AI4Omicw-MB will explore how AI can be applied to genetic data from Manitoba patients to support earlier cancer detection and more personalized treatment in cancer care.

Congratulations to Dr. Ryan Zarychanski on being awarded a Tier 1 Canada Research Chair in Clinical Trials. This prestigious recognition is awarded to researchers who are internationally recognized leaders in their field and conducting groundbreaking research with significant impact. #cancerresearch

At CCMB, nearly 900 doses of injectable treatments are carefully prepared each week inside a specialized “clean room”. With over 8,000 Manitobans diagnosed with cancer each year, our teams are working together to ensure patients receive the right care, closer to home. www.cbc.ca/news/canada/...

Protective equipment, temperature-controlled shipments part of getting cancer treatments to Manitoba patients | CBC News

They call it the clean room. It's where about 900 doses of injectable cancer treatments are compounded each week at the McDermot Avenue building in Winnipeg.

cbc.ca

The TRACTION trial—co-led by CancerCare Manitoba researchers presented yesterday at #ASH2025. Findings from 8,400 patients show pre-op tranexamic acid reduces blood transfusion with no increase in blood clots, even in cancer patients. A major step towards safer surgeries and sustainable blood supply

A recent study from our team confirms that isatuximab, a common myeloma treatment— can now be safely delivered in just 30 minutes instead of 75 minutes. Why it matters: quicker appointments, more comfortable experiences, and more capacity to care for Manitobans. #patientcare #cancercare

🎓 Exciting news! #PROMISE Madox's Warriors Graduate Studentship officially launches today! Check out the details and help spread the word. #MadoxsWarriors #GradStudentship #CHRIM #CCMB #CancerResearch @um-radyfhs.bsky.social @umbmg.bsky.social @cancercaremb.bsky.social @chrimanitoba.bsky.social

🍁Meet the Team Canada of Cancer Research: A Q&A with Dr. Versha Banerji🍁 After early setbacks, Dr. Banerji found her calling in hematology. Through MOHCCN, she and her team study immune dysfunction in chronic lymphocytic leukemia to develop more targeted cancer therapies. tinyurl.com/bdf7w8cv

We are pleased to welcome Dr. Kent Stobart as CancerCare Manitoba’s new President and CEO. A pediatric oncologist and a health care leader, Dr. Stobart brings passion, experience, and a commitment to advancing cancer care and research for all Manitobans. 💙